SUMMARY: These letters call on the House and Senate to include the CREATES Act in the omnibus spending bill. The CREATES Act addresses two anticompetitive tactics some brand-name drug manufacturers have been using to block the ability of more affordable generic alternatives to get into the market and give consumers a choice.

Read the full letter to the Senate here.

Read the full letter to the House here.